Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$112,687,250
-$15,577,995 QoQ
Shares Held
443,703
-15.4% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#9
of 487 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 84.82160364027288.ToString("F0")%
Shared 0.ToString("F0")%
None 15.178396359727115.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. JNJ ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,905,111 | $361,247,147 | |
| 2 | ABBV |
AbbVie Inc.
|
680,730 | $171,298,897 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,169,722 | $150,309,277 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
443,703 | $112,687,250 | |
| 5 | LLY |
ELI LILLY & Co
|
81,026 | $97,185,023 | |
| 6 | BIIB |
Biogen Inc.
|
241,101 | $52,092,282 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
635,252 | $36,603,220 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
192,146 | $24,275,725 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $112,687,250 | 443,703 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $128,265,245 | 524,731 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $121,188,264 | 585,592 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $120,016,988 | 647,271 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $88,861,548 | 581,745 | Shares | Sole | 2026-04-10 | |
| 2025-03-31 | $101,964,568 | 614,837 | Shares | Sole | 2026-04-10 | |
| 2024-12-31 | $92,658,178 | 640,701 | Shares | Sole | 2026-04-10 | |
| 2024-09-30 | $105,428,943 | 650,555 | Shares | Sole | 2026-04-10 | |
| 2024-06-30 | $96,871,778 | 662,779 | Shares | Sole | 2026-04-10 | |
| 2024-03-31 | $63,753,891 | 403,021 | Shares | Sole | 2026-04-10 | |
| 2023-12-31 | $62,237,378 | 397,074 | Shares | Sole | 2026-04-10 | |
| 2023-06-30 | $62,165,836 | 375,579 | Shares | Sole | 2026-04-10 | |
| 2023-03-31 | $47,230,050 | 304,710 | Shares | Sole | 2025-09-02 | |
| 2022-12-31 | $53,827,021 | 304,710 | Shares | Sole | 2023-10-19 | |
| 2022-09-30 | $44,736,136 | 273,850 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $20,098,214 | 113,223 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $19,003,309 | 107,224 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $75,364,375 | 440,547 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $71,405,933 | 442,142 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $72,855,276 | 442,244 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $73,535,284 | 447,431 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $85,137,229 | 540,966 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $81,135,282 | 544,971 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $75,688,753 | 538,212 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $89,012,355 | 678,810 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||